S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.38%) $966.30
USD/EUR
(-0.36%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

实时更新: Fresenius SE & Co. KGaA [FSNUY]

交易所: OTC 部门: Healthcare 工业: Medical Care Facilities
最后更新时间4 May 2024 @ 03:59

1.71% $ 7.73

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 03:59):

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed...

Stats
今日成交量 35 418.00
平均成交量 51 916.00
市值 17.42B
EPS $0 ( 2024-03-19 )
下一个收益日期 ( $0 ) 2024-05-14
Last Dividend $0.247 ( 2023-05-18 )
Next Dividend $0 ( N/A )
P/E 45.47
ATR14 $0.0330 (0.43%)

Fresenius SE & Co. KGaA 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Fresenius SE & Co. KGaA 相关性 - 货币/商品

The country flag -0.16
( neutral )
The country flag -0.34
( neutral )
The country flag 0.00
( neutral )
The country flag -0.26
( neutral )
The country flag 0.41
( neutral )
The country flag 0.45
( neutral )

Fresenius SE & Co. KGaA 财务报表

Annual 2023
营收: $22.30B
毛利润: $5.06B (22.68 %)
EPS: $-1.050
FY 2023
营收: $22.30B
毛利润: $5.06B (22.68 %)
EPS: $-1.050
FY 2022
营收: $40.84B
毛利润: $10.73B (26.26 %)
EPS: $3.77
FY 2021
营收: $37.52B
毛利润: $10.31B (27.48 %)
EPS: $0.815

Financial Reports:

No articles found.

Fresenius SE & Co. KGaA Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.247
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Fresenius SE & Co. KGaA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.07 - good (70.71%) | Divividend Growth Potential Score: 1.745 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.119 2013-05-15
Last Dividend $0.247 2023-05-18
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 11 --
Total Paid Out $2.15 --
Avg. Dividend % Per Year 0.00% --
Score 1.93 --
Div. Sustainability Score 7.07
Div.Growth Potential Score 1.745
Div. Directional Score 4.41 --
Next Divdend (Est)
(2025-04-04)
$0.254 Estimate 3.11 %
Dividend Stability
0.25 Very Poor
Dividend Score
1.93
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TKAGY Ex Dividend Junior 2023-06-12 Annually 0 0.00%
IESFY Ex Dividend Knight 2023-05-16 Semi-Annually 0 0.00%
AZIHY Ex Dividend Junior 2023-05-25 Annually 0 0.00%
PPWLM Ex Dividend Junior 2023-07-19 Quarterly 0 0.00%
ECTM Ex Dividend Junior 2023-05-19 Quarterly 0 0.00%
UUGRY Ex Dividend Junior 2023-06-22 Semi-Annually 0 0.00%
KGFHY Ex Dividend Knight 2023-10-12 Annually 0 0.00%
BTVCY Ex Dividend Junior 2023-06-01 Annually 0 0.00%
SATLF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
FINN Ex Dividend Knight 2023-08-07 Bi-Monthly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.01501.500-0.300-0.450[0 - 0.5]
returnOnAssetsTTM-0.01051.200-0.351-0.421[0 - 0.3]
returnOnEquityTTM-0.02401.500-1.377-2.07[0.1 - 1]
payoutRatioTTM-2.58-1.000-10.0010.00[0 - 1]
currentRatioTTM1.3420.8008.296.63[1 - 3]
quickRatioTTM0.9220.8009.297.43[0.8 - 2.5]
cashRatioTTM0.2751.5009.5910.00[0.2 - 2]
debtRatioTTM0.310-1.5004.83-7.25[0 - 0.6]
interestCoverageTTM2.671.000-0.121-0.121[3 - 30]
operatingCashFlowPerShareTTM7.912.007.3610.00[0 - 30]
freeCashFlowPerShareTTM5.482.007.2610.00[0 - 20]
debtEquityRatioTTM0.739-1.5007.04-10.00[0 - 2.5]
grossProfitMarginTTM0.2331.0009.459.45[0.2 - 0.8]
operatingProfitMarginTTM0.05851.000-0.829-0.829[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3171.0009.359.35[0.2 - 2]
assetTurnoverTTM0.7020.8008.656.92[0.5 - 2]
Total Score7.07

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-8.361.000-0.9450[1 - 100]
returnOnEquityTTM-0.02402.50-0.885-2.07[0.1 - 1.5]
freeCashFlowPerShareTTM5.482.008.1710.00[0 - 30]
dividendYielPercentageTTM3.781.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM7.912.007.3610.00[0 - 30]
payoutRatioTTM-2.581.500-10.0010.00[0 - 1]
pegRatioTTM-0.3381.500-5.590[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1401.0008.990[0.1 - 0.5]
Total Score1.745

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。